Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis.
Zhao X, Qin Y, Li B, Wang Y, Liu J, Wang B, Zhao J, Yin J, Zhang L, Li J, Huang J, Chen K, Liu L, Wu Y.
Zhao X, et al. Among authors: liu l.
J Nanobiotechnology. 2025 Jan 9;23(1):10. doi: 10.1186/s12951-024-03083-2.
J Nanobiotechnology. 2025.
PMID: 39780203